Trial intelligence / Profile preview

Curodont Repair vs Fluoride Varnish for White Spot Lesions

NCT02913885Phase 2Unknown

Sponsor
Cairo University
Start
Jan 2017
Primary completion
Jul 2017
Modality
Peptides, Small Molecules
01

Overview

Phase 2, randomised, single-blind trial of curodont in White spot lesion (WSL) (2 arms), sponsored by Cairo University. Primary endpoint: Change in Patient Satisfaction at 6 months. Status: unknown.

02

Drugs

curodont
03

Conditions

White spot lesion (WSL)

Beyond the preview

Go deeper on NCT02913885.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02913885.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call